Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
Melatonin showed no clear difference in drop‐outs (8 weeks) compared with placebo (low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Fasting blood glucose (8 to 12 weeks) (change from baseline data) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Incidence of SAD (modified ITT) · adults with a history of SAD
It is very uncertain whether agomelatine changes incidence of SAD (modified ITT) compared with placebo (very low certainty).
1 finding from 1 review
Adverse events as N of participants with at least one adverse event subjective and objective · adults with a history of SAD
It is very uncertain whether agomelatine changes number of persons with at least one adverse event within a year compared with placebo (very low certainty).
1 finding from 1 review
Severity of depression (SIGH‐SAD score) at the end of the study · adults with a history of SAD
1 finding from 1 review
Quality of life · adults with a history of SAD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of interpersonal and social functioning · adults with a history of SAD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing at least one severe adverse event · adults with a history of SAD
It is very uncertain whether agomelatine changes number of persons with at least one severe adverse event within a year compared with placebo (very low certainty).
1 finding from 1 review